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Abstract
An understanding of human responses to hypoxia is important for the health of millions of people worldwide who visit, live,
or work in the hypoxic environment encountered at high altitudes. In spite of dozens of studies over the last 100 years, the
basic mechanisms controlling acclimatization to hypoxia remain largely unknown. The AltitudeOmics project aimed to
bridge this gap. Our goals were 1) to describe a phenotype for successful acclimatization and assess its retention and 2) use
these findings as a foundation for companion mechanistic studies. Our approach was to characterize acclimatization by
measuring changes in arterial oxygenation and hemoglobin concentration [Hb], acute mountain sickness (AMS), cognitive
function, and exercise performance in 21 subjects as they acclimatized to 5260 m over 16 days. We then focused on the
retention of acclimatization by having subjects reascend to 5260 m after either 7 (n = 14) or 21 (n = 7) days at 1525 m. At 16
days at 5260 m we observed: 1) increases in arterial oxygenation and [Hb] (compared to acute hypoxia: PaO2 rose
964 mmHg to 4564 while PaCO2 dropped a further 663 mmHg to 2163, and [Hb] rose 1.860.7 g/dL to 1662 g/dL; 2) no
AMS; 3) improved cognitive function; and 4) improved exercise performance by 868% (all changes p,0.01). Upon reascent,
we observed retention of arterial oxygenation but not [Hb], protection from AMS, retention of exercise performance, less
retention of cognitive function; and noted that some of these effects lasted for 21 days. Taken together, these findings
reveal new information about retention of acclimatization, and can be used as a physiological foundation to explore the
molecular mechanisms of acclimatization and its retention.
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Introduction
Millions of people live and work in, or travel to, high altitudes,
and many of them are able to adjust successfully to the hypoxic
environment of very high altitudes (,5000 m), where ambient
oxygen pressure is about half the sea level value. Discovery of the
mechanisms responsible for human acclimatization to hypoxia
could lead to new ways to improve acclimatization and its
retention.
The physiology of how humans respond acutely and adapt to
hypoxia has been explored extensively over the last century, yet
many questions remain about the attributes that best characterize
acclimatization [1]. Most would agree that improving arterial
oxygenation and exercise performance are central tenets of
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acclimatization, and although no studies have focused on the
protection from high-altitude illness that occurs with acclimatiza-
tion, most would also agree such protection is an important aspect
of acclimatization. On the other hand, how cognitive function
responds during acclimatization is largely unknown, except from
anecdotal reports. Intriguing also are suggestions that acclimati-
zation causes functional modifications that persist upon return to
high altitude after weeks, or perhaps even months, at sea level, and
at a time when all known physiological measures of acclimatiza-
tion have returned to normal low altitude values [2–4].
AltitudeOmics is a multifaceted research program on acclima-
tization to high altitude and the retention of acclimatization after
return to low altitude. The goals for AltitudeOmics were 1) to
describe a phenotype for successful acclimatization and assess its
retention—that is—whether adaptive responses persist after
descent to low altitude for one to three weeks, and 2) to use these
findings as a foundation for companion mechanistic studies of the
human transcriptome, epigenome, metabolome, and proteome
(OMICS). Our approach was to study lowland volunteers in the
field who were taken rapidly to 5260 m, where they acclimatized
for 16 days. They then descended to 1525 m for either seven
(n = 14) or 21 (n = 7) days, after which they returned quickly to
5260 m and were retested. This report describes the physiology of
acclimatization and its retention for four key features of
acclimatization: 1) arterial oxygenation and [Hb]; 2) acute
mountain sickness (AMS); 3) cognitive function; and 4) exercise
performance. Of particular interest was the acclimatization
retention displayed upon returning to 5260 m after even three
weeks at low altitude. Subsequent reports will explore changes in
OMICS responses and will attempt to link those responses to the
physiological phenotype of acclimatization and its retention
reported here.
Methods
Ethical Approval and Subject Recruitment
The study was performed according to the Declaration of
Helsinki. It was approved by the Institutional Review Boards of
the Universities of Colorado and Oregon and by the Human
Research Protection Office of the U.S. Department of Defense.
The subjects were informed about the possible risks and
discomforts of participation in the study before giving their written
and verbal consent to participate. Physical examinations and the
U.S. Army Physical Fitness Test (APFT) (push-ups, sit-ups, and a
3.2-km run) [5] were performed to characterize health and fitness
status. Exclusion criteria included: being born at.1500 m; having
traveled to altitudes .1000 m in the past three months (including
air travel); using prescription medications; smoking; being
pregnant or lactating; having a history of serious head injury (loss
of consciousness); self or familial history of migraine; known
hematologic or cardiovascular abnormality (e.g., sickle cell trait,
cardiac arrhythmia); pulmonary function or diffusion capacity for
carbon monoxide ,90% of predicted; or failure to meet the
minimal age/gender standards for the APFT [5]. Seventy-nine
subjects completed the screening. Twenty-four healthy, physically
active subjects were enrolled. Two subjects dropped out for non-
altitude related medical reasons, and one was never healthy at
high altitude due to non-altitude related persistent gastrointestinal
illness. Thus, 21 subjects (12 males and nine females, average age
20.8 yrs, range 19–23 yrs) constitute the AltitudeOmics group of
subjects included in this and subsequent reports (Table 1).
Timeline. Each subject was studied near sea level (SL)
(130 m, average PB = 749 mmHg, Figure 1), and over three study
periods at Mt Chacaltaya, Bolivia; 5260 m; average
PB = 406 mmHg); on the first/second and sixteenth/seventeenth
days at 5260 m (ALT1, ALT16), and again upon reascent to
5260 m, after either seven (n = 14) or 21 (n = 7) days at low altitude
(POST7 or POST21). Baseline studies at SL, including laboratory
(physiologic and OMICS) and field (3.2-km uphill run) tests, were
conducted over a two-week period in Eugene, OR, USA.
Approximately one month after the SL studies, subjects traveled
to Bolivia in pairs on successive days. Upon arrival at El Alto
(4050 m) after an overnight flight, subjects immediately descended
to Coroico, Bolivia (1525 m; PB = 639 mmHg). Subjects rested for
48 hrs in Coroico to limit the effects of jet lag and were then
driven over three hrs to 5260 m. To provide an acute change in
inspired PO2 from 1525 m to 5260 m, subjects breathed
supplemental oxygen (2 L/min, nasal cannula or mask) during
the drive. On arrival at 5260 m, the first subject immediately
began the experimental protocol described below. The second
subject rested while continuing to breathe supplemental oxygen for
, two hrs until the first subject had completed the arterial/venous
catheterization and cognitive testing portion of the protocol. Then
the second subject began the protocol as described for the first
subject. Two subjects were studied per day for ALT1, ALT16,
POST7, and POST21. After completing laboratory testing and
AMS scoring on ALT1, subjects slept overnight on supplemental
oxygen to minimize the risk of developing severe high-altitude
illness. The next morning, subjects completed a 3.2-km uphill run
(305 m elevation gain) before descending by car to La Paz, Bolivia
(3800 m; average PB = 487 mmHg) to continue acclimatizing at a
lower altitude over three nights (ALT2-ALT4). On ALT4 subjects
Table 1. General Subject Characteristics.
ID Gender Age (years) HT (cm) WT (kg) BMI (kg/m2)
001 M 22 184.2 80.8 23.8
002 M 22 181.6 65.4 19.8
003 F 21 166.4 54.3 19.6
004 M 21 181.6 70.7 21.4
005 F 21 160.0 53.2 20.7
006 M 19 170.2 68.1 23.5
007 M 21 184.2 73.3 21.6
010 F 19 163.8 67.6 25.1
011 F 21 169.5 68.0 23.6
012 M 20 181.6 82.4 24.9
013 M 23 182.9 77.0 23.0
014 M 21 186.7 85.4 24.4
015 F 22 168.3 56.7 20.0
017 F 23 174.0 69.9 23.0
018 M 21 180.3 79.9 24.5
019 F 19 176.5 68.0 21.8
020 F 19 165.7 62.2 22.6
021 M 20 182.9 68.9 20.6
022 M 23 180.3 73.8 22.6
023 M 20 179.1 77.8 24.2
025 F 19 172.1 60.9 20.5
Mean 12M/9F 20.8 175.8 69.7 22.4
SD 1.4 7.9 9.0 1.8
Height (HT); Weight (WT); Body Mass Index (BMI).
doi:10.1371/journal.pone.0092191.t001
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visited 5260 m for four to six hrs. On ALT5, they returned to
5260 m, where they remained for an additional 13 days. On
ALT16/17 subjects were tested, as on ALT1/2 prior to
descending by car to 1525 m. To test physiological retention of
acclimatization after living for seven (n = 14) or 21 (n = 7) days at
low altitude (1525 m), subjects returned to 5260 m by car, as they
did on ALT1 but this time without supplemental oxygen, and
completed the POST7/21 testing (detailed below). After comple-
tion of a 3.2-km uphill run on POST7/21, the subjects returned
home. Assignment to POST7 or POST21 was determined by each
subject based on their desire to stay in the field an extra seven or
21 days. While in Bolivia, subjects were housed and fed as a group.
Meals and snacks were kept similar to the subjects’ typical ad
libitum diet. Subjects were instructed to ingest at least three liters of
water each day and to remain physically active.
Experimental Protocol. Testing progressed in the following
general order: 1) radial artery and antecubital vein catheterization;
2) 30-min supine rest, followed by cognitive function testing; 3)
measurement of resting (seated) arterial blood gases and hemo-
globin concentration, and blood draw for OMICS samples; 4)
cycle ergometry exercise testing; 5) AMS symptom scoring; and,
on a separate day, 6) a 3.2-km uphill run. In addition to the studies
presented here, within the framework of AltitudeOmics and
reported separately, we also assessed cerebral blood flow[6] and
cerebral autoregulation [7]; chemical control of breathing [8];
total hemoglobin mass and blood volume compartments; periph-
erally [9] and centrally [10] derived measures of exercise-induced
fatigue; blood flow through intracardiac shunt (patent foramen
ovale) and intrapulmonary arteriovenous anastomoses; and
OMICS responses (transcriptomics, epigenomics, metabolomics,
and proteomics).
Procedures
Anthropometry. Height (cm) was measured at SL only. Body
mass (kg) was recorded at SL, ALT1, ALT16, and POST7/21
using the same scale (Seca 770, Hanover, MD, USA), with the
subject wearing light underwear and no shoes.
Arterial Blood Gases and Hemoglobin
Under local anesthesia (2% lidocaine) a 20–22 G radial artery
catheter (Models RA-04122/RA-04020 Arrow International,
Reading, PA, USA) was placed for the duration of experiments
conducted at SL, ALT1/16, and POST7/21. Arterial blood
samples were drawn anaerobically and immediately analyzed in
duplicate for PaO2, PaCO2, pH (Siemens RAPIDLab 248,
Erlangen, Germany), [Hb] and SaO2 (Radiometer OSM3,
Copenhagen, Denmark). Core temperature was measured using
an ingestible temperature-sensing pill (CorTemp HQInc, Palmet-
to, FL, USA)[11,12]. Blood gases were corrected for core
temperature [11,12]. CaO2 (mL/dL) was calculated as:
CaO2 = 1.39 * [Hb] * (SaO2/100)+(PaO2 * 0.003). The Hill
equation was used to calculate P50 [13]. Resting arterial blood
samples were taken following 10 min of seated rest at SL, ALT1,
ALT16, and POST7/21.
Acute Mountain Sickness
The severity of AMS symptoms was assessed using the Lake
Louise Questionnaire (LLQ), which includes a self-reported
assessment of AMS symptoms (headache, fatigue, gastrointestinal
discomfort, and dizziness) and the shortened Environmental
Symptom Questionnaire (AMS-C). Total LLQ scores that
included headache and were $3 or $6 (out of a possible total
of 12) were diagnostic of moderate or severe AMS, respectively.
Quality of sleep was not included in the total LLQ score because
nights prior to ALT1 and POST7/21 were spent at low altitude.
Recently, in our laboratory, we have published LLQ without using
the sleep question, with no change in sensitivity in identifying
AMS [14,15]. AMS-C is a self-reported 11-question inventory
from which a score $ 0.7 is considered indicative of AMS [16].
AMS symptoms were assessed at SL, ALT1 (in the evening,
Figure 1. Timeline for AltitudeOmics Studies. Each subject completed this study timeline, with n = 14 staying at low altitude for POST7 and
n= 7 staying at low altitude for POST21. Subjects flew from the USA to Bolivia aboard commercial aircraft with no recording of barometric pressure
during the flight; the profile for travel in the figure is therefore approximate.
doi:10.1371/journal.pone.0092191.g001
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10–12 hrs after arrival), ALT16, and POST7/21 (time-matched
to ALT1).
Cognitive Function
The Defense Automated Neurobehavioral Assessment (DANA)
was used to assess neurocognitive function. DANA is a neurocog-
nitive assessment tool that includes a library of open-source,
standardized, cognitive and psychological assessments [17]. Using
a handheld computer, the following nine cognitive function tests
were administered: 1) Simple Reaction Time-1 (measured at the
beginning of neurocognitive testing to gain an understanding of
pure visual-motor response); 2) Simple Reaction Time-2, repeated
at the end of neurocognitive testing to assess diminished reserve of
cognitive effort on reaction time; 3) Procedural Reaction Time, a
measure of choice reaction time and accuracy; 4) Go-No-Go, a
measure of speed, accuracy and impulsivity; 5) Code Substitu-
tion—Simultaneous, a measure of visual scanning and attention,
learning, and immediate recall of digit-symbol pairings; 6) Code
Substitution—Delayed Recall, a measure of short-term memory
for digit-symbol pairings; 7) Spatial Discrimination, a measure of
visuospatial analytic ability; 8) Match to Sample, an assessment of
attention and memory for visuospatial discrimination; and 9)
Sternberg’s Memory Search, a measure of working memory for
letters. Neurocognitive tests were administered before and after the
expedition at SL and once each at ALT1, ALT16 and POST7/21.
Repeat cognitive function tests at SL were similar (p.0.5) and thus
were combined to give one SL score for comparison to changes in
cognitive function at 5260 m. Mean throughput, a measure of
mental efficiency, is calculated as the mean number of correct
responses for each test made within one min [18] and is the
outcome variable reported for all cognitive function variables.
Exercise
Laboratory exercise testing. Incremental exercise tests to maximal
exertion on an electrically-braked cycle ergometer (Velotron Elite,
Racermate, Seattle, WA, USA) were used to assess peak aerobic
power. Subjects completed three-min stages at 70, 100, 130 and
160 Watts, followed by 15 Watts/min increments until they could
no longer maintain pedaling at . 50 rpm. Peak aerobic power
(Watts) was calculated as: work rate of last stage completed +
[(work rate increment) * (time into final stage/duration of stage in
seconds)] [19]. Exercise tests were performed at SL, ALT1, and
ALT16, but not at POST7/21 due to logistical issues.
Field exercise testing. Subjects completed a timed 3.2-km uphill run
as fast as possible, on unpaved roads, with an identical elevation
gain of 305 m. Tests were performed at SL at least 48 hrs before
the laboratory tests and in the morning after an overnight stay on
ALT1, ALT16 and POST7/21. Performance was expressed as
mean running speed in m/s.
Data Analysis
As expected, preliminary analyses revealed higher CaO2 for
males as a result of higher [Hb], across the study (p,0.01 vs.
females); however, since the sex vs. time interaction was not
significant (p.0.05) male and female data were pooled for all
subsequent analyses. For physiological variables, paired t-tests,
with Bonferroni correction for multiple testing, were completed for
comparisons among time points. LLQ, AMS-C scores and
cognitive function tests were evaluated by the Wilcoxon signed
rank test. The Spearman rank order and Pearson product moment
correlations were run to evaluate associations between changes in
arterial blood gases and [Hb] and changes in AMS symptoms,
cognitive function, and physical performance across time. Due to
transportation delays and the technical challenges inherent to field
studies, not all procedures were completed on all subjects at Mt.
Chacaltaya (see Tables S1, S2, S3, S4, S5 for respective sample
sizes). Overall, most subjects completed most tests, with 88% of
arterial blood gas and hematology measurements, 100% comple-
tion of AMS and cognitive function tests, and 95% for the 3.2-km
uphill run. For all parametric statistical comparisons, p,0.01
(Bonferroni correction of 0.05/5) was considered significant, with
p,0.01 for Wilcoxon signed rank test results considered signifi-
cant. Individual data for all responses reported here are presented
in Tables S1, S2, S3, S4, S5. Data in the text are presented as
means 6 standard deviation.
Results
Anthropometry
Height and body mass at SL are presented in Table 1. Body
mass was unchanged from SL to ALT1 (p = NS), then dropped by
2.661.6 kg (p,0.01) from ALT1 to ALT16; it showed no
significant change thereafter (Table S1).
Arterial Blood Gases and Hemoglobin
PaO2, PaCO2, SaO2, and CaO2 were reduced with acute
exposure to 5260 m (SL to ALT1, p,0.01; Figure 2, panels A–C,
Table S2), while pH and P50 increased (p,0.01, Figure 2, panels
D and E) and [Hb] was unchanged (p = NS, Figure 2, panel F).
PaO2, SaO2, CaO2, P50, and [Hb] all increased from ALT1 to
ALT16, while PaCO2 continued to fall (p,0.01, all comparisons)
and pH was unchanged (p = NS; Figure 2). SaO2 at POST7 was
maintained at ALT16 levels. In contrast, PaO2, CaO2, P50, and
[Hb] at POST7 decreased from ALT16 (p,0.01) and approached
ALT1 values. PaCO2 rose at POST7 from ALT16 values and was
significantly different from both ALT1 and ALT16 (p,0.01).
Since subjects studied at POST21 had incomplete arterial blood
gas data at all time points but SL; those data are qualitatively
discussed, but data in the text and figures are at all time points for
the POST7 group only. The pattern of change from ALT16 to
POST21 was similar to that seen from ALT16 to POST7 for
PaO2, PaCO2, SaO2, CaO2, pH, and [Hb], suggesting possible
retention of acclimatized values for SaO2, but less so for PaO2,
PaCO2, CaO2, P50, pH, and [Hb].
Acute Mountain Sickness
LLQ and AMS-C were highly correlated (R2 = 0.72, p,0.001)
and identified the same subjects as AMS positive at ALT1; for
brevity, only the LLQ score is discussed (see Table S3). Eighty-one
percent (17/21) of subjects had AMS (LLQ$3; p,0.01 vs. SL) on
the evening of their first night at 5260 m; of those with AMS
nearly half had severe AMS (LLQ$6; p,0.01vs. SL; Figure 3A).
AMS completely resolved in all subjects as acclimatization
progressed from ALT1 to ALT16. Upon reascent at POST7
subjects remained free from AMS. On POST21, 3/7 of subjects
again developed AMS scores$3 (p = NS vs. ALT16), but none
reported severe AMS. Nobody exhibited HAPE or HACE.
Cognitive Function
Repeat tests at sea level pre-post expedition showed no major
differences between individuals or group values (p.0.5) and were
thus averaged to provide a more robust SL value (Table S4a–c).
Five of nine neurocognitive tests showed marked decrements from
SL to ALT1 (Simple Reaction Time-1, Simple Reaction Time-2,
Code Substitution—Simultaneous, Match to Sample and Proce-
dural Reaction Time, p,0.01, Figure 4); no change from SL to
ALT1 was seen for Code Substitution—Delayed Recall, Spatial
Discrimination, Go-No-Go, and Memory Search (p.0.05) (Table
Human Acclimatization to Hypobaric Hypoxia
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S4a–c). Subsequent analyses focused on the five tests that showed a
change with acute hypoxia. Performance improved on Simple
Reaction Time-1, Simple Reaction Time-2, Code Substitution—
Simultaneous, Match to Sample, and Procedural Reaction Time
as acclimatization progressed from ALT1 to ALT16 (p,0.01,
Figure 4). At POST7, Code Substitution—Simultaneous and
Match to Sample showed retention of acclimatization compared to
ALT16 (p,0.01, Figure 4, panels C and D), with loss of
acclimatization evident for Simple Reaction Time-2, Procedural
Reaction Time (p,0.01, Figure 4, panel B and E), and a trend to
loss of acclimatization noted for Simple Reaction Time-1
(p.0.01,0.05, Figure 4, panel A). No cognitive function tests
showed retention of acclimatization at POST21.
Exercise
Laboratory exercise testing. Peak oxygen uptake at SL was
3.460.8 l/min and fell by 29611% to 2.360.6 l/min at ALT1
(p,0.01), with no change observed from ALT1 to ALT16 (p = NS)
(See Table S5). Peak power output at SL was 265657 W; it fell by
3467% to 171640 W at ALT1 (p,0.01), and like peak oxygen
uptake, it did not improve with acclimatization. Changes in resting
arterial oxygenation and [Hb] from SL to ALT1 to ALT16 were
not correlated with peak oxygen uptake (p = NS).
Field exercise testing. Running speed was 4465% slower at ALT1
compared to SL (p,0.01; Figure 5). Running speed improved
868% from ALT1 to ALT16 (p,0.01) and was maintained at
POST7 (p = NS). Subjects maintained acclimatized (ALT16)
running speed at POST7 despite 13% lower resting [Hb] and
CaO2. After 21 days at low altitude, running speed tended to be
slower than at ALT16 (p = 0.06) and was not significantly different
Figure 2. Arterial Blood Gases and [Hb] During Acclimatization and Upon Reascent. Resting indices of ventilatory and hematological
acclimatization at SL, ALT1, ALT16, and POST7/21 demonstrating acclimatization after 16 days at a constant altitude and the degree of retention in
these variables. *Significantly different vs. SL (p,0.01); { significantly different than ALT1 (p,0.01); `significantly different than ALT16 (p,0.01).
doi:10.1371/journal.pone.0092191.g002
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from ALT1 (p = NS), suggesting a partial loss of acclimatization in
running speed by POST21.
Relationship of AMS, Cognitive Function and Exercise
Performance to Arterial Oxygenation and [Hb]
During acclimatization AMS, cognitive function, and exercise
performance improved, and for AMS and exercise those
improvements were retained upon reascent, with only some tests
of cognitive function showing retention of acclimatization. The
changes that occurred during acclimatization and upon reascent in
PaO2, PaCO2, SaO2, CaO2, P50, pH, and [Hb] were not related
on an individual (all correlations r,0.5) or group basis (all
comparisons p.0.1) to AMS, cognitive function, or exercise
responses. However, the pattern of change with acclimatization in
PaO2, PaCO2, SaO2, CaO2, P50, pH and [Hb] matches the
pattern of change for AMS, cognitive function, and exercise
performance, suggesting an underlying but complex relationship
between oxygenation and other aspects of acclimatization.
Discussion
In this paper, we have presented four aspects of altitude
acclimatization through a 16-day initial exposure to 5260 m, and
upon reascent to the same altitude after either seven or 21 days at
low altitude. We found, as have others before us [20–30], elevated
arterial oxygenation and [Hb], resolution of symptoms of acute
mountain sickness and increased exercise performance after 16
days residence at 5260 m. We also report improvements in
measures of cognitive performance that we believe represent a
novel and important additional indicator of acclimatization. Most
intriguing was finding that after descending to low altitude for one
or three weeks, physiological evidence of acclimatization persisted
upon returning to 5260 m, as manifest by less AMS, retention of
improved exercise performance, and to some extent cognitive
performance.
Physiology of Acclimatization
The elevations in arterial oxygenation and [Hb] from ALT1 to
ALT16 were similar to those measured in individuals acclimatized
for at least 10 days at altitudes ranging from 3800 m to 5260 m
[20,26,29,30]. For example, Lundby et al. reported that [Hb] and
CaO2 increased markedly from SL to two weeks at 4100 m, but
did not rise further at eight weeks [26]. While similar data do not
exist for the rise in PaO2 and fall in PaCO2 with ventilatory
acclimatization at two and eight weeks at a fixed high altitude,
Wagner et al. reported after nine weeks at 5260 m a PaO2 of
5061 mmHg and a PaCO2 of 2160.9, values similar to PaO2
(4563) and PaCO2 (2163) in the present study after 16 days at
5260 m [30]. Thus, it seems that$14 days at 4000 m to 5000 m
results in significant acclimatization, and that this duration of
exposure can be effective to test acclimatization and its subsequent
retention [30].
Sixteen days of acclimatization at 5260 m was effective in
reducing the incidence of AMS from 81% in our subjects upon
acute exposure to 0% at ALT16, a finding consistent with existing
literature [23,24,28]. These findings suggest a new experimental
approach to unraveling the pathophysiology of AMS. To our
knowledge, no pathophysiological studies of AMS have taken
advantage of the complete protection from AMS conferred by
acclimatization by comparing individuals upon acute ascent to
when they are acclimatized, or upon reascent when presumably
the factors that protect from AMS will stand out from other factors
that are epiphenomena to the acclimatization process but not key
to AMS prevention.
This is the first report of complete recovery of cognitive function
to sea level values after acclimatization to high altitude, supporting
the idea that cognitive function is an important outcome of
acclimatization. DANA tests have negligible practice effects (other
than spatial discrimination, which asymptotes after the second
administration) [17]. This was evident in the current study, as no
significant differences were detected between DANA measures on
pre- and post-expedition SL tests. We found that the five tests
showing impairment in acute hypoxia all returned to SL values by
ALT16 (p,0.01, Figure 4). Barcroft et al. reported anecdotal
impairment in cognitive function during acclimatization, but
lacked any quantitative evidence [31]. Other studies have reported
effects on cognitive function in acute hypoxia [32–36] during
experiments and expeditions where the barometric pressure and
environmental conditions were different at each testing point, such
as occurs during a climbing expedition [37–39], and one has
speculated about the recovery of cognitive function with acclima-
tization [40]. However, none of those studies have shown, as in the
present study, that when subjects are studied at the same altitude
over the course of acclimatization that cognitive function improves
to sea level values. DANA tests speed and accuracy in measures
that assess attention, simple discrimination, and immediate and
incidental memory. Although these measures offer an indication of
working memory, they do not assess complex problem-solving and
Figure 3. Development of Acute Mountain Sickness, Its
Resolution with Acclimatization And Prevention Upon Reas-
cent. Percentage of subjects reporting moderate to severe AMS based
on LLQ scores of $3, or $6, respectively. (A) Symptoms of AMS at ALT1
were alleviated at ALT16 and were largely absent with reascent on
POST7/21. (B) Mean PaO2 and median LL AMS scores reveal no
relationship of hypoxemia to AMS. *Significantly different than SL
(p,0.01); {significantly different than ALT1 (p,0.01); `significantly
different than ALT16 (p,0.01).
doi:10.1371/journal.pone.0092191.g003
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decision-making aspects of executive functioning, which may be
especially relevant for people working at high altitudes. Under-
standing the mechanism for the marked resolution of the initial
decrement in cognitive performance that occurs in acute hypoxia
has potential impact [41] for anyone visiting, living, or working at
high altitudes where impaired cognitive dysfunction is a major
challenge [37,38,42].
Our findings for submaximal exercise performance are consis-
tent with other reports showing improvements during acclimati-
zation [22,25,27,43] with no change in peak oxygen consumption
[2,22,26,44–51]. However, in retrospect, we question the practical
relevance of these all-out efforts, as most work or recreational
activities at high altitude are not performed to exhaustion or as fast
as possible. For example, mountaineers try to preserve energy to
sustain efforts across multiple days and might actually put
themselves at risk of serious harm, or death, if they truly reached
the point of exhaustion. Their ability to cover more ground faster
while preserving a functional reserve is a hallmark of acclimati-
zation supported by anecdotal accounts [52,53]. To the best of our
knowledge, only one study before the present report has
objectively measured this type of submaximal performance [43].
The physiology behind the improvement in sustained, self-
regulated submaximal performance at altitude remains unex-
plored [2,22,26,43–52].
Physiological Retention of Acclimatization: Arterial Blood
Gases and Hemoglobin
At POST7/21, PaO2 and PaCO2 values ranged between
ALT16 and ALT1 values, indicating partial retention of ventila-
tory acclimatization. In contrast, SaO2 and pH remained near
ALT16 acclimatized levels on POST7/21. We calculated a
decreased P50 from ALT16 to POST7/21, suggesting a left shift
in the oxyhemoglobin dissociation curve upon reascent as a
possible explanation for the retention of acclimatized values for
SaO2 at POST7/21 [2]. These findings are compatible with one
previous study showing partial retention of ventilatory acclimati-
zation using noninvasive indices of oxygenation and end tidal CO2
levels after eight days at low altitude [2,54]. The drop in [Hb]
from ALT16 to POST7/21 may be due to selective destruction of
the youngest circulating red cells (neocytolysis) upon return to low
altitude [55–58], or potentially an increase in plasma volume [59].
Figure 4. Neurocognitive Function During Acclimatization and Upon Reascent. Five tests of cognitive function revealed marked
decrements in performance from SL to ALT1, and improvement back to sea level values by ALT16. Code Substitution—Simultaneous and Match to
Sample retained levels found at ALT16 on POST7, while Simple Reaction Time-1, Simple Reaction Time-2, and Procedural Reaction Time essentially
reflected a loss of during acclimatization upon reascent at POST7. None of the cognitive function tests showed any retention of acclimatization at
POST21. (tp = throughput = mean number of correct responses made within one min). *Significantly different than SL (p,0.01); {significantly
different vs. ALT1 (p,0.01); `significantly different vs. ALT16 (p,0.01).
doi:10.1371/journal.pone.0092191.g004
Figure 5. Field Exercise Testing During Acclimatization and
Upon Reascent. Uphill running speed plotted as percent change from
sea level improved from ALT1 to ALT16 and was retained at POST7, with
a trend to retention at POST21. *Significantly different vs. SL (p,0.01);
{significantly different vs. ALT1 (p,0.01).
doi:10.1371/journal.pone.0092191.g005
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Physiological Retention of Acclimatization: Acute
Mountain Sickness
Our findings on AMS upon reascent extend the work of others
conducted at lower altitudes in demonstrating that previous
altitude acclimatization confers some protection from AMS
[3,4,60]. The marked efficacy of acclimatization to prevent severe
AMS is underscored by comparison to results from clinical trials
where acetazolamide only reduced the risk of severe AMS by 44%
[61], compared to 100% for acclimatization in our study. Exactly
how acclimatization prevents AMS and other high-altitude
illnesses upon reascent is unclear.
AMS is clearly triggered by hypoxemia, but once the processes
that cause AMS are initiated, the relationship with PaO2, SaO2,
and CaO2 is less clear. This is reflected in Figure 3B where AMS
scores are highest when PaO2 is lowest at ALT1, but when at
POST7 and ALT16, when PaO2 levels are only a few mmHg
higher than ALT1 values, AMS is absent. Additionally, at POST7,
when AMS is absent in all 14 subjects, CaO2 levels are much
lower than at ALT16, suggesting a limited role for CaO2 in the
protection from AMS observed upon reascent. One explanation
may be that the absolute value of PaO2, SaO2, or CaO2 is not the
critical factor, but rather that acute hypoxia sets in motion the
physiological alterations leading to AMS. In other words, perhaps
an individual threshold exists that triggers AMS when crossed
[62]. Unraveling how this occurs may lead to advances in the
understanding of the pathophysiology of high-altitude illnesses.
Physiological Retention of Acclimatization: Cognitive
Function
Cognitive function stands out as a key feature of acclimatization
to hypoxia that is not completely retained at acclimatized levels
upon reascent. The tests that showed retention of acclimatization
at POST7 (Code Substitution—Simultaneous and Match to
Sample) commonly reflect changes in short-term memory. The
tests of reaction time (Simple Reaction Time-1, Simple Reaction
Time-2, Procedural Reaction Time) essentially returned to ALT1
values by POST7, indicating a loss of the improvement in reaction
time seen with acclimatization. Short-term memory and reaction
time appear to represent distinct processes that respond differently
to the changes in arterial blood gases and [Hb] from ALT16 to
POST7. Understanding the mechanisms responsible for acclima-
tization retention or its loss could lead to new insights into the links
between brain oxygenation and cognitive function for persons at
high altitudes.
Physiological Retention of Acclimatization: Exercise
The retention of exercise performance for at least seven days,
with partial retention after 21 days spent at low altitude, has
important implications for everyone living, visiting, or working at
high altitudes. At POST7, and to a lesser extent at POST21,
subjects essentially matched their acclimatized running perfor-
mance. This is the first report of retention of acclimatized exercise
performance upon reascent after de-acclimatizing at low altitude.
As far as we know, only one other study attempted to measure
retention of acclimatized endurance exercise performance [2], but
that study showed no improvement in endurance exercise
performance with acclimatization, likely due to a small sample
size (n = 6), thus rendering testing of retention impossible. As noted
above, all studies [22,25,27,43] but one [2] have shown
improvement in submaximal endurance capacity with acclimati-
zation. The retention of exercise performance shown at POST7
occurred despite significant reductions in resting [Hb] and CaO2.
These findings are contrary to those reporting a direct positive
effect of CaO2 on exercise performance at lower altitudes [25,63],
but agree with those reporting little effect of CaO2 on exercise
performance at higher altitudes (.3500 m) [64–66]. If the
improvement of exercise performance with acclimatization and
its retention upon reascent is not directly related to CaO2, then
other factors must be at play. One possibility is that mechanisms
other than oxygen delivery could boost oxygen transport and thus
exercise performance during acclimatization and upon reascent,
such as elevated circulating blood levels of vasodilatory substances
(e.g., nitric oxide [67] or adenosine [68]) or other, as yet unknown,
processes. Discovering the mechanisms responsible for improving
exercise performance with acclimatization and its retention after
acclimatization has potential relevance to exercise tolerance in
anyone exposed to hypoxia.
Physiological Mechanisms Explaining Acclimatization and
its Retention
Acclimatization transforms a lowlander into someone who is
protected from high-altitude illness, has improved cognitive
function, and has better exercise performance at 5260 m. In the
present study, acclimatization-induced improvements in AMS
symptoms, cognitive function and exercise performance appear to
follow the time course of ventilatory and hematological acclima-
tization. But after extensive analysis, no case was found where the
degree of improvement in AMS symptoms, cognitive function, and
exercise performance was significantly directly correlated to
measured indices of arterial oxygenation and [Hb]. Further,
arterial oxygenation and [Hb] were poorly correlated with the
benefits of acclimatization that persisted upon reascent. Though
not well known, Luft et al. reported on the retention of
acclimatization based on studies conducted in hypobaric chambers
on climbers returning from Nanga Parbat in 1938 [69]. The
measurement of retention was tolerance to very high altitudes
(.8000 m) measured, in part, by deterioration of handwriting.
They noted that neither the hemoglobin concentration nor the
erythrocyte count were responsible for the persistence of
acclimatization. While we acknowledge the inherent limitations
of correlational analyses, the disconnection between ventilatory
and hematological acclimatization and physiological function
suggests that additional mechanisms are involved in acclimatiza-
tion and its retention. These might include physiological responses
that we did not measure, or molecular and cellular responses in a
specific tissue such as brain that cannot be easily measured in
humans. In subsequent reports we will pursue a linkage between
the OMICS responses and the physiological adjustments described
here to explore the mechanisms underlying acclimatization to high
altitude and its retention.
Limitations
Several limitations in the study design and execution should be
considered. This study was completed in the field, in a foreign
country, and with many uncontrolled variables. The rationale for
this approach over a trial in a hypobaric environment where many
more variables could be controlled was that such a large study
could not be completed for a reasonable cost and in a reasonable
time-frame in a hypobaric chamber. Operation Everest II studied
six-to-eight subjects during a 40-day simulated ascent of Mt
Everest. Though many of the time points from Operation Everest
II had data from only four to six subjects, many important
observations were made from these experiments [29,44,70–73].
But to have sufficient statistical power to combine the OMICS and
physiological studies, much larger sample sizes are needed. As far
as the authors know, there is one hypobaric chamber in the world
large enough to accommodate 21 subjects at a time, located in
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Glasgow, Scotland. While we acknowledge the field design as a
limitation, we believe this study makes an important contribution
to understanding acclimatization that can point to future studies
with smaller samples and more focused experimental questions in
controlled hypobaric chamber conditions.
This study was limited to 16 days of acclimatization. While this
was sufficient time to see marked changes in the variables
measured, it is unclear if longer exposure would have resulted in
further improvements in acclimatization or better retention of
acclimatization upon reascent. Also, due to logistical and financial
constraints and to avoid areas of high malarial risk, subjects did
not descend all the way to sea level between exposures. However,
this may not be a major concern, since our results are consistent
with other studies reporting protection from AMS after acclima-
tization [3,4,60]. Only Lyons et al. [3] reported data from a
controlled study of acclimatizing individuals; others used epide-
miological observations suggesting AMS protection from acclima-
tization [4,60]. Also, we made no measurements at low altitude
prior to reascent, so a question remains as to how much of the
reascent responses were present at low altitude such as hyperven-
tilation, resulting in low PaCO2, versus how much was nascent at
low altitude but was rapidly triggered on re-ascent.
An additional concern is that subjects may have de-trained over
the 16 days at high altitude, since they were unable to completely
maintain their regular exercise regimen. When back at low
altitude, subjects resumed their habitual levels of physical activity,
potentially restoring some fitness and confounding our measures of
exercise performance. Also, changes in total and lean body mass
across the study may have affected physical performance [74], but
since changes in body composition and training status are inherent
to life at high altitude, we feel our results have strong practical
relevance.
Finally, the AltitudeOmics project encompasses an extensive
suite of physiological and OMICS measurements, and, in its
entirety, produced more than 60 million individual data points.
Consequently, the data has been partitioned into discrete papers
with the ultimate goal of a series of publications that are
individually robust and as comprehensive as possible. The
physiological parameters included in this paper have historically
been used to describe acclimatization, and thus were deemed
appropriate as a bridge between past studies and the novel
discoveries from AltitudeOmics. Further publications will explore
the process of acclimatization by utilizing additional OMICS and
physiological data whose inclusion excessively widened the scope
of the current paper.
Conclusion
In this study of acclimatization to a very high altitude, we found
improvements in key variables after 16 days that describe an
acclimatized phenotype by partial acclimatization for arterial
oxygenation and [Hb], absence of high-altitude illness, improved
cognition and exercise performance. Another intriguing observa-
tion is that after descending to low altitude for one or three weeks,
evidence of acclimatization persists, as manifested by an acclima-
tized value for SaO2, much less severe AMS, maintained exercise
performance, and to a lesser extent retention of acclimatized
cognitive performance. During the time at low altitude, many of
the changes reflecting ventilatory and hematologic adaptation
returned to or toward the unacclimatized state at the time reascent
measurements were made. In conclusion, this study identifies a
phenotype of successful human acclimatization to hypoxia,
identifies novel aspects of the retention of the acclimatized
phenotype after time at low altitude, and will serve as a foundation
for comparing the phenotype of acclimatization with potential
mechanistic mediators of acclimatization derived from companion
studies of the human transcriptome, epigenome, metabolome, and
proteome.
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